Xilio Therapeutics, INC. (XLO) SEC Filings — 2025

Filings

• Xilio Therapeutics, INC. 8-K Filing — 8-K · Nov 25, 2025
• Xilio's Revenue Surges, But Warrant Liabilities Deepen Net Loss — 10-Q · Nov 13, 2025
• Xilio Therapeutics Files 8-K — 8-K · Nov 7, 2025
• Xilio Seeks Shareholder Nod for Option Repricing, New Stock Plan — DEF 14A · Oct 20, 2025
• Xilio Therapeutics Faces Delisting Notice — 8-K · Oct 3, 2025
• Xilio Therapeutics Files 8-K Report — 8-K · Sep 9, 2025
• Xilio Therapeutics Faces Delisting Concerns — 8-K · Aug 28, 2025
• Xilio's Losses Mount Amid R&D Spend, Cash Position Boosted by Offering — 10-Q · Aug 14, 2025
• Xilio Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 12, 2025
• Xilio Therapeutics Board Changes: New Directors Elected, Two Depart — 8-K · Jun 10, 2025
• Xilio Therapeutics Files 8-K: Material Agreement, Other Events — 8-K · Jun 3, 2025
• Xilio Therapeutics Files 8-K — 8-K · Jun 2, 2025
• Xilio Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Xilio Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 28, 2025
• Xilio Therapeutics to be Delisted from Nasdaq — 8-K · Apr 8, 2025
• Xilio Therapeutics Files 8-K on Financials — 8-K · Mar 11, 2025
• Xilio Therapeutics Files 2024 10-K — 10-K · Mar 11, 2025
• Xilio Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Feb 12, 2025
• Xilio Therapeutics Files 8-K — 8-K · Jan 21, 2025